New Clinical Trial for Ovarian Cancer offered by the Oncology Institute of Hope and Innovation

Share Article

The Oncology Institute of Hope and Innovation announces a new clinical trial available for individuals with Ovarian Cancer.

The Oncology Institute of Hope and Innovation is proud to have access to the latest research, technology and treatment options, including clinical trials for eligible patients. They are dedicated to providing comprehensive medical services to our patients. In their quest to be at the forefront of the latest medical cancer research, the institute participates in numerous clinical trials focused on various types of malignancies that may be of interest to your oncology patients. They are pleased to make the announcement of the following clinical trial for individuals with ovarian cancer which may benefit some of your patients:

A Randomized, Double-Blinded, Placebo-Controlled Trial of Cvac
(Augologous Dendritic Cells Pulsed with Recombinant Human Fusion
Protein [Mucin 1-Glutathione S-Transferqase] Coupled to Oxidized Polymannose)
as Maintenance Treatment in Patients with Epithelial Ovarian Cancer (EOC) IN Complete Remission Following First-Line Chemotherapy

The primary objective is to assess the efficacy, in terms of progression-free survival (PFS), of Cvac as compared with placebo for the maintenance treatment of patients with epithelial ovarian cancer (EOC) in complete remission (CR) following first-line chemotherapy.

If you have patients who you feel may qualify for this trial, or have questions regarding eligibility, please contact any one of their 9 locations to schedule an evaluation.

About The Oncology Institute:
The Oncology Institute of Hope and Innovation is committed to providing superior, compassionate and state-of-the-art medical care. Offering programs to help patients and families cope with the challenges that are brought on by cancer and strive to optimize their quality of life, comprehensive and realistic treatment goals are tailored to every person's unique needs and decided upon in partnership with the patients and their families. Dedicated to excel in cancer prevention, diagnosis and education through our exceptional team of physicians, nurse practitioners, nurses, medical assistants and office staff, The Oncology Institute of Hope and Innovation has 9 Southern California locations in the cities of Anaheim, Downey, Glendale, Long Beach, Lynwood, Montebello, Torrance, Santa Ana, and Whittier. For more information please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Angela Teng
Visit website